Department of Healthcare Transformation Initiatives, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA.
Department of Healthcare Transformation Initiatives, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA.
J Affect Disord. 2023 Jan 1;320:590-594. doi: 10.1016/j.jad.2022.09.131. Epub 2022 Sep 29.
In the United States, suicide is one of the serious public health problems and a major cause of death. Several researchers and clinical settings use the patient health questionnaires (PHQ-9) to gauge depression and psychological distress among adults and to predict suicide and death. This study aimed to assess the sensitivity, specificity, and predictive potential of suicide Q9 of the PHQ-9 compared to the Columbia-suicide severity rating scale (C-SSRS).
Adults aged 19 or older, identified with a primary mood disorder diagnosis during their initial clinic visit between 2012 and 2020 from the National Network of Depression Centers, were included in the study. The accuracy of the PHQ-9 suicide item was compared with the gold standard, the C-SSRS.
Out of 2677 study participants, 31.6 % (n = 846) and 11.65 % (n = 312) had positive responses to the PHQ-9 suicide item and C-SSRS response, respectively. The sensitivity of the PHQ-9 compared to the C-SSR was 74.7 % (95%CI: 69.6 %-79.2 %), specificity 74.1 % (95%CI: 72.3 %-75.8 %), positive predictive value 27.5 % (95%CI: 24.6 %-30.6 %), and negative predictive value 95.7 % (95%CI: 94.7 %-96.5 %). The secondary analysis results showed better validity results of the PHQ-9 suicide item when compared to the suicide ideation item of the C-SSRS.
This study is among mood disorder patients so additional research would be necessary among populations with different conditions.
For initial suicide screening, the PHQ-9 suicide item would over identify patients as at risk for suicide and the C-SSRS should be used mood disorder clinics to identify suicide risk.
在美国,自杀是严重的公共卫生问题之一,也是主要死因之一。一些研究人员和临床环境使用患者健康问卷(PHQ-9)来评估成年人的抑郁和心理困扰,并预测自杀和死亡。本研究旨在评估 PHQ-9 自杀问题与哥伦比亚自杀严重程度评定量表(C-SSRS)相比的敏感性、特异性和预测潜力。
研究纳入了 2012 年至 2020 年期间在国家抑郁中心网络的首次就诊中被诊断为原发性心境障碍的年龄在 19 岁或以上的成年人。PHQ-9 自杀项目的准确性与金标准 C-SSRS 进行了比较。
在 2677 名研究参与者中,分别有 31.6%(n=846)和 11.65%(n=312)对 PHQ-9 自杀项目和 C-SSRS 反应呈阳性。与 C-SSR 相比,PHQ-9 的敏感性为 74.7%(95%CI:69.6%-79.2%),特异性为 74.1%(95%CI:72.3%-75.8%),阳性预测值为 27.5%(95%CI:24.6%-30.6%),阴性预测值为 95.7%(95%CI:94.7%-96.5%)。二次分析结果表明,PHQ-9 自杀项目的有效性结果优于 C-SSRS 的自杀意念项目。
本研究仅针对心境障碍患者,因此在具有不同条件的人群中还需要进一步的研究。
对于初步自杀筛查,PHQ-9 自杀项目会过度识别有自杀风险的患者,而 C-SSRS 应该在心境障碍诊所中用于识别自杀风险。